FPGEE 2026 Practice Exam for NABP – The Complete All-in-One Guide to Exam Success!

The S.T.E.P.S. program, which stands for System for Thalidomide Education and Prescribing Safety, was initiated specifically to minimize fetal exposure to Thalomid (thalidomide). This medication is known for its severe teratogenic effects, meaning it can cause significant birth defects if taken during pregnancy. The program is designed to ensure that both prescribers and patients are educated about the risks associated with thalidomide, and it imposes strict guidelines regarding its use, including requirements for patient registration, contraceptive measures, and regular pregnancy tests for women of childbearing potential. By implementing this safety monitoring system, the program effectively aims to prevent fetal exposure to thalidomide and protect potential pregnancies.